title: New drugs for the treatment of lung cancer. The Tokyo Cooperative Oncology Group.
authors.forename: H
authors.initials: H
authors.lastname: Niitani
authors.forename: M
authors.initials: M
authors.lastname: Fukuoka
authors.forename: K
authors.initials: K
authors.lastname: Furuse
authors.forename: S
authors.initials: S
authors.lastname: Kudoh
authors.forename: Y
authors.initials: Y
authors.lastname: Kurita
authors.forename: T
authors.initials: T
authors.lastname: Ohnoshi
authors.forename: N
authors.initials: N
authors.lastname: Saijoh
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001952:Bridged-Ring Compounds / Q000627:therapeutic use; D002166:Camptothecin / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D043823:Taxoids; D014748:Vinca Alkaloids / Q000627:therapeutic use; D000093542:Gemcitabine
chemical_list: D000970:Antineoplastic Agents; D001952:Bridged-Ring Compounds; D009944:Organoplatinum Compounds; D043823:Taxoids; D014748:Vinca Alkaloids; D003841:Deoxycytidine; C080625:taxane; C053989:nedaplatin; D002166:Camptothecin; D000093542:Gemcitabine